专利检索 ap:("Frank Osterroth" OR "Christoph Uherek" OR "Christoph Bruecher" OR "Benjamin Daelken" OR "Andre Engling" OR "Thomas Haeder" OR "Andrea Wartenberg-Demand" OR "Gabriele Niemann" OR "Chantal Zuber" OR "Niklas Czeloth" OR "Silke Aigner" OR "Steffen Zeng") AND inv:"Andre Engling" 第 1 页

1.

发明授权
Uses of immunoconjugates targeting CD138 有权
标题翻译：靶向CD138的免疫缀合物的使用

公开(公告)号：US09289509B2

公开(公告)日：2016-03-22

申请号：US12774705

申请日：2010-05-05

申请人： Frank Osterroth , Christoph Uherek , Christoph Bruecher , Benjamin Daelken , Andre Engling , Thomas Haeder , Andrea Wartenberg-Demand , Gabriele Niemann , Chantal Zuber , Niklas Czeloth , Silke Aigner , Steffen Zeng , Gregor Schulz

发明人： Frank Osterroth , Christoph Uherek , Christoph Bruecher , Benjamin Daelken , Andre Engling , Thomas Haeder , Andrea Wartenberg-Demand , Gabriele Niemann , Chantal Zuber , Niklas Czeloth , Silke Aigner , Steffen Zeng , Gregor Schulz

IPC分类号： A61K39/395 , A61K47/48 , B82Y5/00

CPC分类号： A61K47/48276 , A61K47/6425 , A61K47/66 , A61K47/6851 , B82Y5/00

摘要： Disclosed are methods and treatment regimes that include the administration of immunconjugates targeting CD138 to combat diseases. The immunoconjugate is either used as the sole active ingredient, as part of a treatment regime or as part of an anticancer combination.

摘要翻译： 公开的方法和治疗方案包括施用靶向CD138的免疫接种物来对抗疾病。免疫缀合物既可用作单一活性成分，也可用作治疗方案的一部分或作为抗癌组合的一部分。

2.

发明申请
USES OF IMMUNOCONJUGATES TARGETING CD138 有权
标题翻译：使用免疫球蛋白靶向CD138

公开(公告)号：US20110123554A1

公开(公告)日：2011-05-26

申请号：US12774705

申请日：2010-05-05

申请人： Frank Osterroth , Christoph Uherek , Christoph Bruecher , Benjamin Daelken , Andre Engling , Thomas Haeder , Andrea Wartenberg-Demand , Gabriele Niemann , Chantal Zuber , Niklas Czeloth , Silke Aigner , Steffen Zeng

发明人： Frank Osterroth , Christoph Uherek , Christoph Bruecher , Benjamin Daelken , Andre Engling , Thomas Haeder , Andrea Wartenberg-Demand , Gabriele Niemann , Chantal Zuber , Niklas Czeloth , Silke Aigner , Steffen Zeng

IPC分类号： A61K39/395 , A61P35/00 , A61P29/00 , A61P19/08

CPC分类号： A61K47/48276 , A61K47/6425 , A61K47/66 , A61K47/6851 , B82Y5/00

摘要： Disclosed are methods and treatment regimes that include the administration of immunconjugates targeting CD138 to combat diseases. The immunoconjugate is either used as the sole active ingredient, as part of a treatment regime or as part of an anticancer combination.

摘要翻译： 公开的方法和治疗方案包括施用靶向CD138的免疫接种物来对抗疾病。免疫缀合物既可用作单一活性成分，也可用作治疗方案的一部分或作为抗癌组合的一部分。